Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Kamada Ltd KMDA

Healthcare Biotechnology
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune... see more

Recent & Breaking News (NDAQ:KMDA)

Kamada Announces Proposed Public Offering of Ordinary Shares

GlobeNewswire July 27, 2017

Kamada to Host Second Quarter 2017 Financial Results Conference Call on August 1

GlobeNewswire July 27, 2017

Kamada Submits Proposed Phase 3 Protocol to FDA for Inhaled Alpha-1 Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

GlobeNewswire July 20, 2017

Mid-Afternoon Market Update: Steelcase Tumbles Following Disappointing Earnings Report; Staples Shares Surge

Benzinga.com  June 22, 2017

Mid-Day Market Update: Oracle Surges On Earnings Beat; Kamada Shares Plummet

Benzinga.com  June 22, 2017

Mid-Morning Market Update: Markets Mostly Flat; Accenture Posts In-Line Q3 Earnings

Benzinga.com  June 22, 2017

Kamada Announces Withdrawal of European Marketing Authorization Application for Inhaled Alpha-1 Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency Disease

GlobeNewswire June 22, 2017

Kamada Receives Additional Milestone Payment Under GLASSIA® Exclusive Supply and Distribution Agreement with Shire

GlobeNewswire June 12, 2017

15 Biggest Mid-Day Losers For Wednesday

Benzinga.com  June 7, 2017

Kamada Provides Update on Clinical Program for Alpha-1 Antitrypsin IV for Treatment of Graft-Versus-Host Disease

GlobeNewswire June 7, 2017

Kamada Announces Appointment of Michal Stein, M.D., as Vice President and Medical Director

GlobeNewswire June 5, 2017

Kamada Presents Updated Data from Phase 2 Clinical Trial of Inhaled Alpha-1-Antitrypsin for Treatment of Alpha-1 Antitrypsin Deficiency at 2017 American Thoracic Society International Conference

GlobeNewswire May 24, 2017

Investor Network: Kamada Ltd to Host Earnings Call

Accesswire May 16, 2017

Kamada Reports 2017 First Quarter Financial Results

GlobeNewswire May 16, 2017

Kamada to Host First Quarter 2017 Financial Results Conference Call on May 16

GlobeNewswire May 8, 2017

Kamada to Host R&D Day Focused on Graft versus Host Disease (GvHD)

GlobeNewswire March 2, 2017

Kamada Announces Collaboration with Massachusetts General Hospital for Proof of Concept Study Evaluating Benefit of Liquid Alpha-1 Antitrypsin on Liver Preservation Prior to Transplantation

GlobeNewswire February 21, 2017

Kamada Announces Appointment of Biopharmaceutical Industry Veteran, Gwen Melincoff, to its Board of Directors

GlobeNewswire February 8, 2017

Kamada Reports Financial Results for the Fourth Quarter and Full-Year 2016

GlobeNewswire February 6, 2017

Kamada to Host Fiscal Year 2016 Financial Results Conference Call on February 6

GlobeNewswire February 1, 2017